Table 5.

Lumbar osteopenia/osteoporosis

Lumbar spine	Group A	Group B	Group C Total sample
Benefited	Stabilization	Not evaluable	Total patients
38% (9 patients)	33% (8 patients)	29% (7 patients)	45% (24 patients)
50% (9 patients)	44% (8 patients)	6% (l patients)	34% (18 patients)
64% (7 patients) 47% (25 patients)	27% (3 patients) 36% (19 patients)	9% (1 patients) 17% (9 patients)	21% (11 patients) 100% (53 patients)

Regarding the 53 patients with lumbar osteopenia/osteoporosis at baseline: 25/53 (47.17%) had a beneficial effect, 19/53 (35.89%) had a stabilization and in 9/53 (16.98%) the effect was not evaluable.